Arcutis Biotherapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Arcutis Biotherapeutics, Inc.
31.90
−2.47%
vs ±10.2% implied · ×0.24
shaded = implied · ▲▼ = realized
Linked news
NewsFund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Suvretta Capital ManagementSuvretta | $326.1M | 9.42% | +0.89% | |
| 2 | BlackRockBlackRockindex-like | $276.5M | 7.99% | +14.62% | |
| 3 | Frazier Life Sciences ManagementFrazier Life Sciences | $258.9M | 7.48% | 0.00% | |
| 4 | Rubric Capital ManagementRubric | $216.9M | 6.26% | 0.00% | |
| 5 | Polar Capital HoldingsPolar Capital | $173.2M | 5.00% | +16.59% | |
| 6 | State StreetState Streetindex-like | $152.7M | 4.41% | −7.52% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $130.8M | 3.78% | +2.41% | |
| 8 | Morgan StanleyMorgan Stanley | $116.7M | 3.37% | +5.50% | |
| 9 | Jennison AssociatesJennison | $110.6M | 3.20% | −15.29% | |
| 10 | D. E. ShawD. E. Shaw | $103.6M | 2.99% | +58.22% | |
| 11 | UBS GroupUBS | $87.4M | 2.52% | +0.11% | |
| 12 | Bank of AmericaBank of America | $78.3M | 2.26% | +34.49% | |
| 13 | Geode Capital ManagementGeodeindex-like | $78.2M | 2.26% | −2.06% | |
| 14 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $63.7M | 1.84% | +24.27% | |
| 15 | Orbimed AdvisorsOrbimed | $53.5M | 1.55% | new | |
| 16 | Franklin ResourcesFranklin Resources | $50.6M | 1.46% | −15.97% | |
| 17 | American Century CompaniesAmerican Century Companies | $50.5M | 1.46% | +31.56% | |
| 18 | Goldman Sachs GroupGoldman Sachs | $43.7M | 1.26% | +4.08% | |
| 19 | Jupiter TopcoJupiter Topco | $37.0M | 1.07% | — | |
| 20 | Oberweis Asset Management Inc/Oberweis Asset Management Inc/ | $36.0M | 1.04% | +0.51% | |
| 21 | Gilder Gagnon HoweGilder Gagnon Howe | $34.4M | 0.99% | −69.49% | |
| 22 | GW&K Investment ManagementGW&K | $33.8M | 0.98% | +30.32% | |
| 23 | Citadel AdvisorsCitadel | $33.3M | 0.96% | +1191.79% | |
| 24 | Pivotal bioVenture Partners Investment AdvisorPivotal bioVenture Partners Investment Advisor | $33.2M | 0.96% | −6.68% | |
| 25 | BamcoBamco | $32.9M | 0.95% | +16.87% |
271 managers report $3.5B of Arcutis Biotherapeutics on form 13F for the quarter ended Jun 30 '26. 31 of them hold 80% of it; Suvretta is largest at 9.42%.
Expected move
Inputsspot 32.07exp Nov 20ATM strike 32.5ATM straddle 4.95IV 80%